← Leaderboards
Andrea Malaspina
University Of Miami School Of Medicine
$1,153,959
Attributed
$3,461,876
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $796.3K · FY2018–23$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,461,876 · 1
By mechanism
U01$3,461,876 · 1
Top collaborators
- Michael Benatar5 shared
- Mary-Louise Rogers5 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Gbenga Godwin Ogedegbe$43,167,440
- David Loewenstein$16,535,333
- Rosie E Curiel Cid$6,251,764
- Giovanni Piedimonte$7,475,461
- Mary-Louise Rogers$1,153,959
Others in their field
Other Emerging Leaders on “Dose”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Beth Baseler · Leidos Biomedical Research, Inc.$52,807,683
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
Research focus
DoseDisease Natural HistoryDisease HeterogeneityDisease ProgressionAnimal ModelBiologicalBiological MarkersAmyotrophic Lateral SclerosisDipeptidesC9orf72Candidate MarkerBiobankCerebrospinal FluidCharacteristicsClinical DataClinical DevelopmentBiomarker ValidationClinical TrialsCohortBloodComplexCoupledDecision MakingDrug Development
Grant awards (5)
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)$630,895
U01 · FY2023 · NS
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)$604,771
U01 · FY2022 · NS
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)$700,180
U01 · FY2021 · NS
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)$729,722
U01 · FY2019 · NS
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)$796,308
U01 · FY2018 · NS